BeyondSpring Inc. (NASDAQ: BYSI)
$1.7000
-0.0400 ( -2.02% ) 2.5K
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.
Market Data
Open
$1.7000
Previous close
$1.7400
Volume
2.5K
Market cap
$70.47M
Day range
$1.7150 - $1.7600
52 week range
$0.7777 - $4.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 18 | Aug 29, 2024 |
| 6-k | Form 6-K | 2 | Aug 06, 2024 |
| 6-k | Form 6-K | 5 | Jun 12, 2024 |
| 20-f | Annual reports | 26 | Apr 29, 2024 |
| 6-k | Form 6-K | 1 | Mar 18, 2024 |
| 6-k | Form 6-K | 2 | Feb 26, 2024 |
| 6-k | Form 6-K | 19 | Feb 02, 2024 |
| 6-k | Form 6-K | 1 | Jan 16, 2024 |
| 6-k | Form 6-K | 2 | Jan 10, 2024 |
| 6-k | Form 6-K | 2 | Dec 18, 2023 |